The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| IQVIA HLDGS INC | COM | 46266C105 | 110,635 | 617,484 | SH | SOLE | 617,484 | 0 | 0 | ||
| MICHAELS COS INC | COM | 59408Q106 | 686,914 | 52,798,929 | SH | SOLE | 52,798,929 | 0 | 0 | ||
| VERITIV CORP | COM | 923454102 | 28,770 | 1,383,840 | SH | SOLE | 1,383,840 | 0 | 0 | ||
| ATENTO S A | SHS | L0427L105 | 2,129 | 156,574 | SH | SOLE | 156,574 | 0 | 0 | ||
| SURGERY PARTNERS INC | COM | 86881A100 | 767,478 | 26,455,651 | SH | SOLE | 26,455,651 | 0 | 0 | ||
| CEREVAL THERAPEUTICS HOLDINGS, INC | COM | 15678U128 | 1,005,284 | 60,632,356 | SH | SOLE | 60,632,356 | 0 | 0 | ||
| ADVANTAGE SOLUTIONS INC. | COM CL A | 00791N102 | 38,061 | 2,890,000 | SH | SOLE | 2,890,000 | 0 | 0 | ||